NCT05796973
- Conditions
- Adenocarcinoma, Adnexal Diseases, Breast Cancer, +42 more
- Locations
-
- Tampere University Hospital Tampere, Länsi-Suomi, Finland
Clinical trial condition
Metastatic Prostate Adenocarcinoma
Explore clinical trials studying Metastatic Prostate Adenocarcinoma. Study availability and eligibility vary by location and protocol.
25 public trials
13 recruiting studies
Metastatic Prostate Adenocarcinoma trial results
NCT06850545
- Conditions
- Metastatic Prostate Adenocarcinoma, PSMA PET-Positive Castration-Resistant Prostate Cancer
- Locations
-
- Kuopio University Hospital Kuopio, Northern Savonia, Finland
NCT05054296
- Conditions
- Biochemically Recurrent Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +12 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Not Yet Recruiting
Study of PSMA-targeted Therapy and Androgen Receptor Suppression in Low-volume Metastatic ProstatE Cancer: SPARKLE Trial
NCT07650240
- Conditions
- Adenocarcinoma of the Prostate, Advanced Prostate Adenocarcinoma, Advanced Prostate Cancer, +19 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Not Yet Recruiting
Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones
NCT06982222
- Conditions
- Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, Breast Neoplasms, +26 more
- Locations
-
Not specified
NCT02099864
- Conditions
- Castration-Resistant Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +14 more
- Locations
-
- UCSF Medical Center-Mount Zion San Francisco, California, United States
- OHSU Knight Cancer Institute Portland, Oregon, United States
NCT05573789
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +9 more
- Locations
-
- Hellenic Cooperative Oncology Group Athens, Greece
NCT04685811
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
- Locations
-
- Weill Cornell Medicine New York, United States
Active, Not Recruiting
ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer
NCT04471974
- Conditions
- Castration-Resistant Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +13 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
- University of Chicago Evergreen Park, Illinois, United States
- University of Michigan Ann Arbor, Michigan, United States
Active, Not Recruiting
Testing the Safety of Different Doses of Olaparib Given Radium-223 for Men With Advanced Prostate Cancer With Bone Metastasis
NCT03317392
- Conditions
- Castration-Resistant Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +10 more
- Locations
-
- UC San Diego Moores Cancer Center La Jolla, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- Smilow Cancer Center/Yale-New Haven Hospital New Haven, Connecticut, United States
- Yale University New Haven, Connecticut, United States